CLadribine Tablets: Collaborative Study to Evaluate the Impact

Recruiting

18 years - 65 years

All

Phase N/A

10 participants needed

1 Location

Brief description of study

The purpose of this study is to better understand the mechanism of action of cladribine tablets. The study will generate hypotheses regarding the impact of cladribine tablet activity in the CNS by assessing the cerebrospinal fluid (CSF) levels of lymphocyte subsets, neuronal injury markers, & soluble immunological markers in study participants with MS before & during treatment with cladribine tablets, & the association of these CSF markers with corresponding blood markers and clinical outcomes.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Multiple Sclerosis,Multiple Sclerosis
Age: 18 years - 65 years
Gender: All

Multiple Sclerosis Male and Female Age 18-65

Updated on 04 Aug 2024. Study ID: 842908

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

CLadribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System BiomarKers in Multiple Sclerosis

Brief description of study

Eligibility of study

Find a site

Interested in the study